These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12060630)

  • 1. Detection of circulating breast tumor cells by differential expression of marker genes.
    Bosma AJ; Weigelt B; Lambrechts AC; Verhagen OJ; Pruntel R; Hart AA; Rodenhuis S; van 't Veer LJ
    Clin Cancer Res; 2002 Jun; 8(6):1871-7. PubMed ID: 12060630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
    Schröder CP; Ruiters MHJ; de Jong S; Tiebosch ATMG; Wesseling J; Veenstra R; de Vries J; Hoekstra HJ; de Leij LFMH; de Vries EGE
    Int J Cancer; 2003 Sep; 106(4):611-618. PubMed ID: 12845661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients.
    Weigelt B; Bosma AJ; Hart AA; Rodenhuis S; van 't Veer LJ
    Br J Cancer; 2003 Apr; 88(7):1091-4. PubMed ID: 12671691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
    Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
    BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
    Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
    Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry.
    López-Guerrero JA; Gilabert PB; González EB; Sanz Alonso MA; Pérez JP; Talens AS; Oraval EA; de la Rubia Comos J; Boix SB
    J Hematother; 1999 Feb; 8(1):53-61. PubMed ID: 10192302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of gene expression profiling in heterogeneous clinical samples.
    Rodrıguez-Gonzalez FG; Mustafa DA; Mostert B; Sieuwerts AM
    Methods; 2013 Jan; 59(1):47-58. PubMed ID: 22652627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.
    Watson MA; Ylagan LR; Trinkaus KM; Gillanders WE; Naughton MJ; Weilbaecher KN; Fleming TP; Aft RL
    Clin Cancer Res; 2007 Sep; 13(17):5001-9. PubMed ID: 17785550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous expression of tumor-associated genes in disseminated breast cancer cells.
    Zieglschmid V; Hollmann C; Gutierrez B; Krehan A; Kaul S; Böcher O
    Anticancer Res; 2007; 27(4A):1769-76. PubMed ID: 17649771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
    Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.
    Austrup F; Uciechowski P; Eder C; Böckmann B; Suchy B; Driesel G; Jäckel S; Kusiak I; Grill HJ; Giesing M
    Br J Cancer; 2000 Dec; 83(12):1664-73. PubMed ID: 11104564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time RT-PCR systems for CTC detection from blood samples of breast cancer and gynaecological tumour patients (Review).
    Andergassen U; Kölbl AC; Mahner S; Jeschke U
    Oncol Rep; 2016 Apr; 35(4):1905-15. PubMed ID: 26848098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of molecular cytokeratin 19 reverse transcriptase polymerase chain reaction (CK19 RT-PCR) and immunocytochemical detection of micrometastatic breast cancer cells in hematopoietic harvests.
    Traystman MD; Cochran GT; Hake SJ; Kuszynski CA; Mann SL; Murphy BJ; Pirruccello SJ; Zuvanich E; Sharp JG
    J Hematother; 1997 Dec; 6(6):551-61. PubMed ID: 9483190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.
    Zieglschmid V; Hollmann C; Mannel J; Albert W; Jaeschke-Melli S; Eckstein B; Hillemann T; Greten TF; Gross E; Böcher O
    Anticancer Res; 2007; 27(4A):1823-32. PubMed ID: 17649779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR.
    Dardaei L; Shahsavani R; Ghavamzadeh A; Behmanesh M; Aslankoohi E; Alimoghaddam K; Ghaffari SH
    Clin Biochem; 2011 Mar; 44(4):325-30. PubMed ID: 21130081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.